List of Oncology Medication For

Chronic Disease

Specialty medications are used to treat patients with complex and/or rare diseases; have special dosage, storage, handling, and administration requirements; and require high touch patient care and monitoring services (eg, transplant, oncology, MS, hepatitis).

BRENZAVVY (bexagliflozin) Tablets

Diabetes

Brand Name: BRENZAVVY Generic Name: (bexagliflozin)
BRENZAVVY (bexagliflozin) is used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise

Brand Name:	BRENZAVVY
Generic Name:	bexagliflozin
Strength:	Tablets: 20 mg
Manufacturer:	TheracosBio
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “BRENZAVVY (bexagliflozin)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for BRENZAVVY (bexagliflozin) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Cabozantinib capsules

Kidney, Thyroid

cabozantinib capsules
for oral use Initial U.S. Approval: 2012

Cabometyx (cabozantinib) is a medication used for the treatment of advanced renal cell carcinoma.

Facts about cabozantinib capsules

DISEASE INDICATIONS-Kidney Cancer
MANUFACTURER-Ipsen Pharma
USAGE-Oral
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada,
Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “cabozantinib capsules” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

CAMZYOS (mavacamten) capsules

Cardiology

CAMZYOS (mavacamten) capsules for oral use Initial U.S. Approval: 2022

Camzyos is used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (obstructive HCM). Hypertrophic cardiomyopathy (HCM) is a condition where the walls of the heart chamber (left ventricle) contract harder and become thicker than normal.

Brand Name:	CAMZYOS
Generic Name:	mavacamten
Strength:	Capsules: 2.5 mg, 5 mg, 10 mg, and 15 mg
Manufacturer:	Bristol-Myers Squibb
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “CAMZYOS (mavacamten) capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for CAMZYOS (mavacamten) capsules price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

CAPRELSA (vandetanib) Tablets

Thyroid

CAPRELSA (vandetanib) tablets, for oral use Initial U.S. Approval:2011

CAPRELSA is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. Vandetanib is Generic Name for the trade name drug Caprelsa®. Caprelsa® is approved by the FDA. Date of approval: April 6, 2011.

Brand Name:	CAPRELSA
Generic Name:	vandetanib
Strength:	• Tablets: 100 mg and 300 mg
Manufacturer:	AstraZeneca Pharmaceuticals LP
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “CAPRELSA (vandetanib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

carboplatin Injection

Ovarian

carboplatin Injection

Carboplatin is a medicine that is used to treat cancer of the ovaries. It acts by interfering with the division of rapidly multiplying cells, particularly cancer cells.

Facts about carboplatin Injection

Approval Date: 1989
Proprietary Name: On Request
Active Ingredient(s): carboplatin Injection
Current indications: ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import carboplatin Injection” based on the information you provide.

CISPLATIN for injection

Ovarian, Bile Duct Cancer, Bladder

CISPLATIN for injection
for intravenous use Initial U.S. Approval: 1978

Cisplatin for injection is a platinum-based drug indicated for the treatment of: • Advanced testicular cancer • Advanced ovarian cancer • Advanced bladder cancer

Facts about CISPLATIN for injection

Approval Date: 1978
Proprietary Name: On Request
Active Ingredient(s): CISPLATIN for injection
Dosage Forms And Strengths: Lyophilized powder: Single-dose vials containing 50 mg
Company: WG Critical Care
Current indications: • Advanced testicular cancer • Advanced ovarian cancer • Advanced bladder cancer
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import CISPLATIN for injection” based on the information you provide.

Cladribine Tablets

Cladribine tablets, for oral use Initial U.S. Approval: 1993

Generic Name – Mavenclad
Medicine Type – Capsules / Oral
Manufacturer Name – Merck
Approval Year – 2019
Approved by – U.S. Food and Drug Administration (FDA)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import cladribine tablets” based on the information you provide.

Cysteamine Bitartrate Capsules

Chronic Disease

cysteamine bitartrate
delayed-release capsules, for oral use

cysteamine bitartrate is a cystine-depleting agent indicated for the treatment of nephropathic cystinosis in adult and pediatric patients 2 years of age and older. Cysteamine is used to treat cystinosis. It is available by mouth (capsule and extended release capsule) and in eye drops.

Facts about cysteamine bitartrate capsules

Approval Date: 1991
Proprietary Name: PROCYSBI (cysteamine bitartrate)
Active Ingredient(s): cysteamine bitartrate
Dosage Forms And Strengths: Delayed-release capsules: 25 mg and 75 mg
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Bayer Pharmaceuticals In
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “cysteamine bitartrate capsules” based on the information you provide.

DEFENCATH (taurolidine, heparin) Solution

Kidney

Brand Name: DEFENCATH Generic Name: (taurolidine, heparin)
DEFENCATH (taurolidine, heparin) is used to reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter.

The U.S. Food and Drug Administration has approved Defencath (taurolidine and heparin) catheter lock solution (CLS) to reduce catheter-related bloodstream infections in adult patients with kidney failure who are receiving chronic hemodialysis (HD) through a central venous catheter (CVC). Defencath is indicated in this limited and specific patient population.

Defencath CLS is available as a sterile, preservative-free, clear, aqueous-based solution in 3ml and 5ml dosages

Brand Name:	DEFENCATH
Generic Name:	(taurolidine, heparin)
Strength:	DEFENCATH is a sterile catheter lock solution available in single dose vials in the following strengths: 3 mL containing taurolidine 40.5 mg/3 mL (13.5 mg/mL), and heparin 3,000 USP Units/3 mL (1,000 USP Units/mL 5 mL containing taurolidine 67.5 mg/5 mL (13.5 mg/mL), and heparin 5,000 USP Units/5 mL (1,000 USP Units/mL)
Manufacturer:	CorMedix Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “DEFENCATH (taurolidine, heparin)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for DEFENCATH (taurolidine, heparin) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Difelikefalin Injection

Kidney

KORSUVA (difelikefalin) injection,
for intravenous use Initial U.S. Approval: 2021

KORSUVA is a kappa opioid receptor agonist indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD). KORSUVA (difelikefalin) is a kappa opioid receptor agonist. Difelikefalin is a synthetic peptide with a single stereoisomer and is present as an acetate salt.

Facts about difelikefalin Injection

Approval Date: 2021
Proprietary Name: On Request
Active Ingredient(s): pruritus associated with chronic kidney disease (CKD-aP)
Dosage Forms And Strengths: Injection: 65 mcg /1.3 mL (50 mcg/mL) of difelikefalin.
International non-proprietary name (INN) or common name: difelikefalin injection
Therapeutic area (MeSH): moderate to severe itching
Marketing: Vifor (International) Inc.
EMA Approved: 2021
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import difelikefalin injection” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Chronic Disease

Brand Name: BRENZAVVY Generic Name: (bexagliflozin) BRENZAVVY (bexagliflozin) is used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise

cabozantinib capsules for oral use Initial U.S. Approval: 2012

Facts about cabozantinib capsules

Access the best support services globally

CAMZYOS (mavacamten) capsules for oral use Initial U.S. Approval: 2022

CAPRELSA (vandetanib) tablets, for oral use Initial U.S. Approval:2011

carboplatin Injection

Facts about carboplatin Injection

Access the best support services globally

CISPLATIN for injection for intravenous use Initial U.S. Approval: 1978

Facts about CISPLATIN for injection

Access the best support services globally

Cladribine tablets, for oral use Initial U.S. Approval: 1993

Access the best support services globally

cysteamine bitartrate delayed-release capsules, for oral use

Access the best support services globally

Brand Name: DEFENCATH Generic Name: (taurolidine, heparin) DEFENCATH (taurolidine, heparin) is used to reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter.

KORSUVA (difelikefalin) injection, for intravenous use Initial U.S. Approval: 2021

Facts about difelikefalin Injection

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

Brand Name: BRENZAVVY Generic Name: (bexagliflozin)
BRENZAVVY (bexagliflozin) is used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise

cabozantinib capsules
for oral use Initial U.S. Approval: 2012

CISPLATIN for injection
for intravenous use Initial U.S. Approval: 1978

cysteamine bitartrate
delayed-release capsules, for oral use

Brand Name: DEFENCATH Generic Name: (taurolidine, heparin)
DEFENCATH (taurolidine, heparin) is used to reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter.

KORSUVA (difelikefalin) injection,
for intravenous use Initial U.S. Approval: 2021